Ben Moree, PhD profile page

Ben Moree is a Principal Scientist, Applications Development at Quantum-Si. His work at Quantum-Si has focused on the development of commercial applications and workflows for the next-generation protein sequencing technology. Prior to joining Quantum Si, Ben worked at BlueLight Therapeutics where he led drug discovery programs on difficult-to-drug oncology targets and helped develop the core technology platform. Ben received his PhD in Biochemistry from Stanford University where he studied chromatin epigenetics.